Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqi Fuwei Mixture in locally advanced gastric cancer
NCT07098026Recruiting
- Sponsor
- Hunan Cancer Hospital
- Start
- May 2025
- Primary completion
- Dec 2028
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Randomised, double-blind trial in gastric cancer (GC) comparing Shenqi Fuwei Mixture with Placebo (2 arms). Primary endpoint: Event-Free Survival at 60 months. Started May 2025; status: recruiting.
02
Drugs
Shenqi Fuwei Mixture
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07098026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07098026.